
Antibody-enhanced hepatitis E virus nanofiltration in the course of the manufacture of human immunoglobulin
Background: Circulation of hepatitis E virus (HEV) in areas the place plasma is sourced for the manufacture of plasma-derived medicinal merchandise (PDMPs) has prompted verification of HEV clearance. HEV exists as quasi lipid-enveloped (LE) and non-lipid-enveloped (NLE) types, which is perhaps of relevance for HEV clearance from manufacturing processes of antibody-containing PDMPs with solvent/detergent (S/D) therapy upstream of additional clearance steps.
Research design and strategies: Presence of various HEV particles in shares utilized in clearance research was investigated, with nanofilters graded across the assumed HEV particle sizes and by gradient centrifugation. HEV elimination by 35-nm nanofiltration was investigated within the presence or absence of HEV antibodies, in buffer in addition to in immunoglobulin (IG) manufacturing course of intermediates.
Outcomes: HEV particles in step with LE, NLE, and an “intermediate” (IM) phenotype, obtained after S/D therapy, have been seen in several HEV shares. Within the absence of HEV antibodies, log discount components (LRFs) of 4.Zero and a couple of.5 have been obtained by 35-nm nanofiltration of LE and IM HEV, in step with the bigger and smaller sizes of those phenotypes. Addition of HEV antibodies enhanced IM HEV elimination round 1000-fold (LRF, 5.6). Efficient (LRF, >4.eight and >4.0) HEV elimination was obtained for the nanofiltration processing step for IG intermediates with various HEV antibody content material.
Conclusion: HEV spikes utilized in clearance research ought to be fastidiously chosen, as variations in physicochemical properties would possibly have an effect on HEV clearance. Antibody-mediated enhancement of HEV nanofiltration was demonstrated in IG course of intermediates even at low HEV antibody focus, illustrating the robustness of this manufacturing step.
Antibody-protein binding and conformational modifications: figuring out allosteric signalling pathways to engineer a greater effector response
Quite a few monoclonal antibodies have been developed efficiently for the therapy of varied ailments. However, the event of biotherapeutic antibodies is advanced, costly, and time-consuming, and to facilitate this course of, cautious structural evaluation past the antibody binding website is required to develop a extra efficacious antibody.
- On this work, we targeted on protein antigens, since they induce the most important antibody modifications, and supply fascinating instances to check and distinction. The buildings of 15 anti-protein antibodies have been analysed to check the antigen-bound/unbound types.
- Surprisingly, three different courses of binding-induced modificationshave beenrecognized. In school (B1), the antigen binding fragment distorted considerably, and we discovered modifications within the loop area of the heavy chain’s fixed area; this corresponds nicely with anticipated allosteric actions. In school (B2), we discovered modifications in the identical loop area with out the general distortion.
- In school (B3), these modifications didn’t current, and solely local modificationson the complementarity figuring outareashave beendiscovered. Consequently, structural evaluation of antibodies is essential for therapeutic growth.
- Cautious analysis of allosteric actionshave to be undertaken to develop higher effector responses, particularly in the course of the transformation of those antibodies from small fragments on the discovery stage to full antibodies on the subsequent growth levels.

controlpeptidecomprimary-antibodies
PSMB8 antibody |
|||
70R-19589 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal PSMB8 antibody |
PSMB8 Antibody |
|||
43134-100ul | SAB | 100ul | EUR 302.4 |
PSMB8 antibody |
|||
70R-13550 | Fitzgerald | 100 ul | EUR 548.4 |
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
PSMB8 antibody |
|||
22848-100ul | SAB | 100ul | EUR 468 |
PSMB8 Antibody |
|||
BF0434 | Affbiotech | 200ul | EUR 540 |
Psmb8/ Rat Psmb8 ELISA Kit |
|||
ELI-15652r | Lifescience Market | 96 Tests | EUR 1063.2 |
PSMB8 Conjugated Antibody |
|||
C43134 | SAB | 100ul | EUR 476.4 |
Anti-PSMB8 antibody |
|||
STJ11100809 | St John's Laboratory | 100 µl | EUR 495.6 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
Anti-PSMB8 antibody |
|||
STJ29479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
A73468-050 | EpiGentek | 50 ul | EUR 377.3 |
PSMB8 Polyclonal Antibody |
|||
A73468-100 | EpiGentek | 100 ul | EUR 577.5 |
PSMB8 Polyclonal Antibody |
|||
A73468 | EpiGentek |
|
|
PSMB8 siRNA |
|||
20-abx930156 | Abbexa |
|
|
PSMB8 siRNA |
|||
20-abx930157 | Abbexa |
|
|
PSMB8 siRNA |
|||
20-abx904317 | Abbexa |
|
|
pOTB7-PSMB8 |
|||
PVT18497 | Lifescience Market | 2 ug | EUR 277.2 |
PSMB8 Antibody, HRP conjugated |
|||
1-CSB-PA018886LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, FITC conjugated |
|||
1-CSB-PA018886LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, Biotin conjugated |
|||
1-CSB-PA018886LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
PSMB8 Rabbit pAb |
|||
A7340-100ul | Abclonal | 100 ul | EUR 369.6 |
PSMB8 Rabbit pAb |
|||
A7340-200ul | Abclonal | 200 ul | EUR 550.8 |
PSMB8 Rabbit pAb |
|||
A7340-20ul | Abclonal | 20 ul | EUR 219.6 |
PSMB8 Rabbit pAb |
|||
A7340-50ul | Abclonal | 50 ul | EUR 267.6 |
PSMB8 Blocking Peptide |
|||
BF0434-BP | Affbiotech | 1mg | EUR 234 |
anti-PSMB8 (1A5) |
|||
LF-MA30618 | Abfrontier | 100 ul | EUR 632.4 |
Description: Mouse Monoclonal to PSMB8 |
Monoclonal PSMB8 Antibody, Clone: 1A5 |
|||
AMM02864G | Leading Biology | 0.1ml | EUR 633.6 |
Description: A Monoclonal antibody against Human PSMB8. The antibodies are raised in Mouse and are from clone 1A5. This antibody is applicable in WB and IHC, ICC, E |
Anti-PSMB8 / LMP7 Monoclonal Antibody |
|||
M02188-2 | BosterBio | 100ug | EUR 476.4 |
Description: Rabbit Monoclonal PSMB8 / LMP7 Antibody. Validated in IP, IF, WB and tested in Human, Mouse, Rat. |
Rat PSMB8 shRNA Plasmid |
|||
20-abx984734 | Abbexa |
|
|
Human PSMB8 shRNA Plasmid |
|||
20-abx953843 | Abbexa |
|
|
Mouse PSMB8 shRNA Plasmid |
|||
20-abx971337 | Abbexa |
|
|
PSMB8 protein (His tag) |
|||
80R-2608 | Fitzgerald | 100 ug | EUR 386.4 |
Description: Purified recombinant PSMB8 protein |
Canine PSMB8 ELISA KIT |
|||
ELI-15651d | Lifescience Market | 96 Tests | EUR 1113.6 |
PSMB8 Recombinant Protein (Human) |
|||
RP085356 | ABM | 100 ug | Ask for price |
PSMB8 Recombinant Protein (Rat) |
|||
RP222629 | ABM | 100 ug | Ask for price |
PSMB8 Recombinant Protein (Mouse) |
|||
RP165287 | ABM | 100 ug | Ask for price |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
20-abx141396 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
20-abx114776 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
20-abx006453 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
abx011689-100ul | Abbexa | 100 ul | EUR 493.2 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
abx028154-400ul | Abbexa | 400 ul | EUR 627.6 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
abx028154-80l | Abbexa | 80 µl | EUR 343.2 |
Proteasome subunit beta type-8 (PSMB8) Antibody |
|||
20-abx211178 | Abbexa |
|
|
Proteasome subunit beta type-8 (PSMB8) Antibody |
|||
20-abx211851 | Abbexa |
|
|
Monoclonal PSMB8 Antibody (monoclonal) (M01), Clone: 1B3 |
|||
AMM03954G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A Monoclonal antibody against Human PSMB8 (monoclonal) (M01). The antibodies are raised in Mouse and are from clone 1B3. This antibody is applicable in WB, IHC and IF, IP, E |
[KO Validated] PSMB8 Rabbit pAb |
|||
A19933-100ul | Abclonal | 100 ul | EUR 492 |
[KO Validated] PSMB8 Rabbit pAb |
|||
A19933-200ul | Abclonal | 200 ul | EUR 685.2 |
[KO Validated] PSMB8 Rabbit pAb |
|||
A19933-20ul | Abclonal | 20 ul | EUR 265.2 |
[KO Validated] PSMB8 Rabbit pAb |
|||
A19933-50ul | Abclonal | 50 ul | EUR 344.4 |
PSMB8 ELISA Kit (Dog) (OKEH03975) |
|||
OKEH03975 | Aviva Systems Biology | 96 Wells | EUR 1012.8 |
Description: Description of target: ;Species reactivity: Dog;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.064 ng/mL |
PSMB8 ELISA Kit (Human) (OKCD02695) |
|||
OKCD02695 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
Description: Description of target: The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB5 by PSMB8 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues. Acts as a major component of interferon gamma-induced sensitivity. Plays a key role in apoptosis via the degradation of the apoptotic inhibitor MCL1. May be involved in the inflammatory response pathway. In cancer cells, substitution of isoform 1 (E2) by isoform 2 (E1) results in immunoproteasome deficiency. Required for the differentiation of preadipocytes into adipocytes.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.117 ng/mL |
Psmb8 ORF Vector (Rat) (pORF) |
|||
ORF074211 | ABM | 1.0 ug DNA | EUR 607.2 |
PSMB8 ELISA Kit (Human) (OKEH07770) |
|||
OKEH07770 | Aviva Systems Biology | 96 Wells | EUR 1310.4 |
Description: Description of target: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.06ng/mL |
PSMB8 ORF Vector (Human) (pORF) |
|||
ORF028453 | ABM | 1.0 ug DNA | EUR 486 |
Psmb8 ORF Vector (Mouse) (pORF) |
|||
ORF055097 | ABM | 1.0 ug DNA | EUR 607.2 |
PSMB8 sgRNA CRISPR Lentivector set (Human) |
|||
K1740301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Psmb8 sgRNA CRISPR Lentivector set (Rat) |
|||
K6921501 | ABM | 3 x 1.0 ug | EUR 406.8 |
Psmb8 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4425601 | ABM | 3 x 1.0 ug | EUR 406.8 |
Human Proteasome subunit beta type-8 (PSMB8) |
|||
1-CSB-EP018886HU | Cusabio |
|
|
Description: Recombinant Human Proteasome subunit beta type-8(PSMB8) expressed in E.coli |
PSMB8 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K1740302 | ABM | 1.0 ug DNA | EUR 184.8 |
PSMB8 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K1740303 | ABM | 1.0 ug DNA | EUR 184.8 |
PSMB8 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K1740304 | ABM | 1.0 ug DNA | EUR 184.8 |
Psmb8 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K6921502 | ABM | 1.0 ug DNA | EUR 184.8 |
Psmb8 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K6921503 | ABM | 1.0 ug DNA | EUR 184.8 |
Psmb8 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K6921504 | ABM | 1.0 ug DNA | EUR 184.8 |
Psmb8 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4425602 | ABM | 1.0 ug DNA | EUR 184.8 |
Psmb8 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4425603 | ABM | 1.0 ug DNA | EUR 184.8 |
Psmb8 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4425604 | ABM | 1.0 ug DNA | EUR 184.8 |
PSMB8 Protein Vector (Human) (pPB-C-His) |
|||
PV113810 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Human) (pPB-N-His) |
|||
PV113811 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Human) (pPM-C-HA) |
|||
PV113812 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Human) (pPM-C-His) |
|||
PV113813 | ABM | 500 ng | EUR 662.4 |
Recombinant Human PSMB8 Protein, His, E.coli-1mg |
|||
QP13190-1mg | EnQuireBio | 1mg | EUR 3308.4 |
Recombinant Human PSMB8 Protein, His, E.coli-20ug |
|||
QP13190-20ug | EnQuireBio | 20ug | EUR 241.2 |
Recombinant Human PSMB8 Protein, His, E.coli-5ug |
|||
QP13190-5ug | EnQuireBio | 5ug | EUR 186 |
PSMB8 Protein Vector (Rat) (pPB-C-His) |
|||
PV296842 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Rat) (pPB-N-His) |
|||
PV296843 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Rat) (pPM-C-HA) |
|||
PV296844 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Rat) (pPM-C-His) |
|||
PV296845 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Mouse) (pPB-C-His) |
|||
PV220386 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Mouse) (pPB-N-His) |
|||
PV220387 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV220388 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Mouse) (pPM-C-His) |
|||
PV220389 | ABM | 500 ng | EUR 723.6 |
Psmb8 3'UTR GFP Stable Cell Line |
|||
TU167173 | ABM | 1.0 ml | Ask for price |
Psmb8 3'UTR Luciferase Stable Cell Line |
|||
TU216964 | ABM | 1.0 ml | Ask for price |
Psmb8 3'UTR GFP Stable Cell Line |
|||
TU266964 | ABM | 1.0 ml | Ask for price |
Psmb8 3'UTR Luciferase Stable Cell Line |
|||
TU117173 | ABM | 1.0 ml | Ask for price |
PSMB8 3'UTR GFP Stable Cell Line |
|||
TU069046 | ABM | 1.0 ml | EUR 1672.8 |
PSMB8 3'UTR Luciferase Stable Cell Line |
|||
TU019046 | ABM | 1.0 ml | EUR 1672.8 |
PSMB8 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV700471 | ABM | 1.0 ug DNA | EUR 616.8 |
PSMB8 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV700475 | ABM | 1.0 ug DNA | EUR 616.8 |
PSMB8 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV700476 | ABM | 1.0 ug DNA | EUR 616.8 |
Dog PSMB8/ Proteasome subunit beta type-8 ELISA Kit |
|||
E0091Do | Sunlong | 1 Kit | EUR 860.4 |
Human Proteasome subunit β type 8(PSMB8) ELISA kit |
|||
E01P0873-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human Proteasome subunit β type 8(PSMB8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Proteasome subunit β type 8(PSMB8) ELISA kit |
|||
E01P0873-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human Proteasome subunit β type 8(PSMB8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Proteasome subunit β type 8(PSMB8) ELISA kit |
|||
E01P0873-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human Proteasome subunit β type 8(PSMB8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Proteasome subunit β type 8(PSMB8) ELISA kit |
|||
E06P0873-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Goat Proteasome subunit β type 8(PSMB8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Proteasome subunit β type 8(PSMB8) ELISA kit |
|||
E06P0873-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Goat Proteasome subunit β type 8(PSMB8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Antibody profiling of a Borreliella burgdorferi (Lyme illness) C6 antibody optimistic, symptomatic Rottweiler and her pups
Lyme illness (LD) is a tick-transmitted illness attributable to Borreliella burgdorferi (Bb). Temporal research of maternal antibody (Ab) profiles in Bb contaminated pregnant canine and their pups haven’t been performed. On this research, Ab profiles of a client-owned Bb C6 Ab optimistic Rottweiler and her 9 pups have been assessed.
The dam introduced with lameness 12 days previous to parturition and was C6 Ab optimistic with a Quant C6 Ab focus of 237U/mL. Therapy with amoxicillin was initiated and 11 days later 9 pups have been delivered. Screening of the sera from the dam and pups towards Bb cell lysates and a panel of antigens revealed related immunoreactivity profiles.
Whereas antigen-specific IgG and IgM reactivity continued within the dam for at the least 7 months, a fast decline in IgG particular for BBA36, BBK53, BB0238, BBA73 and outer floor protein (Osp) E within the pups occurred between days 29 and 52 post-parturition. In distinction, Ab particular for DbpA and the diagnostic antigens VlsE (C6) and OspF, remained elevated within the pups.
Sera from the dam displayed potent complement-dependent bactericidal exercise towards Bb. Sera from the pups was additionally bactericidal however primarily by means of a complement-independent mechanism. Lastly, single dose vaccination of the dam at day 51 post-parturition with a LD subunit vaccine consisting of OspA and an OspC chimeritope triggered a broad anti-OspC Ab response indicative of an anamnestic response. Though this research targeted on a single case, these findings add to our data of maternal Ab profiles and can help the interpretation of serological assays in pups delivered by a Bb C6 Ab optimistic canine.
Anti-Resistin (2H8) |
|||
YF-MA18970 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to Resistin |
Anti-Resistin (4C8) |
|||
YF-MA18971 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to Resistin |
Anti-Resistin (6H8) |
|||
YF-MA18972 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to Resistin |
Anti-Resistin (4H8) |
|||
YF-MA18973 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to Resistin |
Anti-Resistin (6C3) |
|||
YF-MA18974 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to Resistin |
Human Resistin |
|||
90233-A | BPS Bioscience | 5 µg | EUR 130 |
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli. |
Human Resistin |
|||
90233-B | BPS Bioscience | 25 µg | EUR 205 |
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli. |
Anti-Resistin/RETN Antibody |
|||
PA1473 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-Resistin/RETN Antibody |
|||
PB9412 | BosterBio | 100ug/vial | EUR 352.8 |
Resistin |
|||
GT15031 | Neuromics | 100 ug | EUR 662.4 |
Resistin |
|||
RA19059 | Neuromics | 100 ul | EUR 451.2 |
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
Human Resistin (RETN) |
|||
1-CSB-EP019573HU | Cusabio |
|
|
Description: Recombinant Human Resistin(RETN) expressed in E.coli |
Human Resistin Antibody |
|||
32138-05111 | AssayPro | 150 ug | EUR 313.2 |
Recombinant Human Resistin |
|||
7-01519 | CHI Scientific | 5µg | Ask for price |
Recombinant Human Resistin |
|||
7-01520 | CHI Scientific | 25µg | Ask for price |
Recombinant Human Resistin |
|||
7-01521 | CHI Scientific | 1mg | Ask for price |
Resistin, human recombinant |
|||
4559-100 | Biovision | each | EUR 874.8 |
Resistin, human recombinant |
|||
4559-1000 | Biovision | each | EUR 6127.2 |
Resistin, human recombinant |
|||
4559-25 | Biovision | each | EUR 307.2 |
Canine Resistin(Resistin) ELISA Kit |
|||
QY-E70171 | Qayee Biotechnology | 96T | EUR 511.2 |
rHu Resistin |
|||
AK9086-0005 | Akron Biotech | 5µg | Ask for price |
rHu Resistin |
|||
AK9086-0025 | Akron Biotech | 25µg | Ask for price |
rHu Resistin |
|||
AK9086-0100 | Akron Biotech | 100µg | Ask for price |
rHu Resistin |
|||
AK9086-1000 | Akron Biotech | 1mg | Ask for price |
Resistin antibody |
|||
70R-RG001 | Fitzgerald | 100 ug | EUR 418.8 |
Description: Affinity purified Goat polyclonal Resistin antibody |
Resistin antibody |
|||
70R-RG003 | Fitzgerald | 50 ug | EUR 327.6 |
Description: Affinity purified Goat polyclonal Resistin antibody |
Resistin antibody |
|||
70R-RG005 | Fitzgerald | 50 ug | EUR 327.6 |
Description: Affinity purified Goat polyclonal Resistin antibody |
Resistin antibody |
|||
70R-RR018 | Fitzgerald | 100 ug | EUR 360 |
Description: Affinity purified Rabbit polyclonal Resistin antibody |
Resistin antibody |
|||
70R-51393 | Fitzgerald | 100 ul | EUR 292.8 |
Description: Purified Polyclonal Resistin antibody |
Resistin antibody |
|||
70R-12369 | Fitzgerald | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal Resistin antibody |
Resistin antibody |
|||
70R-12461 | Fitzgerald | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal Resistin antibody |
Resistin antibody |
|||
70R-12463 | Fitzgerald | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal Resistin antibody |
Resistin antibody |
|||
70R-14012 | Fitzgerald | 100 ug | EUR 386.4 |
Description: Affinity purified Rabbit polyclonal Resistin antibody |
Resistin protein |
|||
30R-2640 | Fitzgerald | 25 ug | EUR 362.4 |
Description: Purified recombinant Human Resistin protein |
Resistin protein |
|||
30R-2641 | Fitzgerald | 25 ug | EUR 380.4 |
Description: Purified recombinant Mouse Resistin protein |
Resistin protein |
|||
30R-2642 | Fitzgerald | 25 ug | EUR 362.4 |
Description: Purified recombinant Rat Resistin protein |
Resistin antibody |
|||
20R-1870 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal Resistin antibody |
Resistin antibody |
|||
20R-1872 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal Resistin antibody |
Resistin protein |
|||
30R-AR019 | Fitzgerald | 25 ug | EUR 327.6 |
Description: Purified recombinant Human Resistin protein |
Resistin protein |
|||
30R-AR020 | Fitzgerald | 25 ug | EUR 327.6 |
Description: Purified recombinant Human Resistin protein |
Resistin protein |
|||
30R-AR032 | Fitzgerald | 25 ug | EUR 327.6 |
Description: Purified recombinant Human Resistin protein |
Resistin antibody |
|||
10R-R122A | Fitzgerald | 500 ug | EUR 327.6 |
Description: Mouse monoclonal Resistin antibody |
Resistin Protein |
|||
20-abx262050 | Abbexa |
|
|
Resistin Protein |
|||
20-abx262253 | Abbexa |
|
|
Resistin Protein |
|||
20-abx262254 | Abbexa |
|
|
Resistin Protein |
|||
20-abx262255 | Abbexa |
|
|
Resistin Antibody |
|||
R30545 | NSJ Bioreagents | 100 ug | EUR 419 |
Resistin Antibody |
|||
R32326 | NSJ Bioreagents | 100 ug | EUR 419 |
Resistin Antibody |
|||
5561-100 | Biovision | each | EUR 379.2 |
Resistin Antibody |
|||
5561-30T | Biovision | each | EUR 175.2 |
Resistin Antibody |
|||
5997-100 | Biovision | each | EUR 379.2 |
Resistin Antibody |
|||
5997-30T | Biovision | each | EUR 175.2 |
Resistin Antibody |
|||
5999-100 | Biovision | each | EUR 379.2 |
Resistin Antibody |
|||
5999-30T | Biovision | each | EUR 175.2 |
Human Resistin ELISA KIT |
|||
CSB-E06884h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
Description: Quantitativesandwich ELISA kit for measuring Human Resistin in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human Resistin ELISA KIT |
|||
1-CSB-E06884h | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Resistin in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human Resistin ELISA kit |
|||
E01R0351-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Resistin ELISA kit |
|||
E01R0351-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Resistin ELISA kit |
|||
E01R0351-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
human Resistin ELISA KIT |
|||
CN-04165H1 | ChemNorm | 96T | EUR 530.4 |
human Resistin ELISA KIT |
|||
CN-04165H2 | ChemNorm | 48T | EUR 351.6 |
Human Resistin ELISA Kit |
|||
EHR0358 | Abclonal | 96Tests | EUR 625.2 |
Human Resistin ELISA kit |
|||
55R-E50 | Fitzgerald | 96 wells | EUR 1413.6 |
Description: ELISA kit for the detection of Human Resistin in the research laboratory |
Human Resistin ELISA kit |
|||
55R-1714 | Fitzgerald | 1 kit | EUR 805.2 |
Description: ELISA kit for the detection of Human Resistin in the research laboratory |
Human Resistin ELISA kit |
|||
55R-2127 | Fitzgerald | 96 tests | EUR 919.2 |
Description: ELISA Kit for detection of Resistin in the research laboratory |
Recombinant Human Resistin Mutant |
|||
7-01525 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Resistin Mutant |
|||
7-01526 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Resistin Mutant |
|||
7-01527 | CHI Scientific | 1mg | Ask for price |
human Resistin ELISA KIT |
|||
201-12-0339 | SunredBio | 96 tests | EUR 528 |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Resistin (RETN) Protein |
|||
20-abx068871 | Abbexa |
|
|
Human Resistin (RETN) Protein |
|||
abx670217-25ug | Abbexa | 25 ug | EUR 661.2 |
Human Resistin (RETN) Protein |
|||
20-abx651562 | Abbexa |
|
|
Resistin, human recombinant protein |
|||
P1051-.025 | ApexBio | 25 µg | EUR 375.6 |
Description: Resistance-to-insulin (Resistin), also known as adipocyte-specific secretory factor (ADSF), is a 10 kDa secreted cysteine-rich peptide hormone. Resistin is a tissue-specific cytokine and inhibits insulin?s ability to stimulate glucose uptake. |
Resistin, human recombinant protein |
|||
P1051-.1 | ApexBio | 100 µg | EUR 1052.4 |
Description: Resistance-to-insulin (Resistin), also known as adipocyte-specific secretory factor (ADSF), is a 10 kDa secreted cysteine-rich peptide hormone. Resistin is a tissue-specific cytokine and inhibits insulin?s ability to stimulate glucose uptake. |
Resistin, human recombinant protein |
|||
P1051-1 | ApexBio | 1 mg | EUR 7826.4 |
Description: Resistance-to-insulin (Resistin), also known as adipocyte-specific secretory factor (ADSF), is a 10 kDa secreted cysteine-rich peptide hormone. Resistin is a tissue-specific cytokine and inhibits insulin?s ability to stimulate glucose uptake. |